These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 32299301)

  • 1. Nicotinic acetylcholine receptors (rs1051730) gene polymorphism and surfactant protein D level in chronic obstructive pulmonary disease.
    El Gayed E; Elhelbawy RH; Elhelbawy NG
    Br J Biomed Sci; 2020 Oct; 77(4):213-215. PubMed ID: 32299301
    [No Abstract]   [Full Text] [Related]  

  • 2. Polymorphisms in surfactant protein-D are associated with chronic obstructive pulmonary disease.
    Foreman MG; Kong X; DeMeo DL; Pillai SG; Hersh CP; Bakke P; Gulsvik A; Lomas DA; Litonjua AA; Shapiro SD; Tal-Singer R; Silverman EK
    Am J Respir Cell Mol Biol; 2011 Mar; 44(3):316-22. PubMed ID: 20448057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surfactant protein D multimerization and gene polymorphism in COPD and asthma.
    Fakih D; Akiki Z; Junker K; Medlej-Hashim M; Waked M; Salameh P; Holmskov U; Bouharoun-Tayoun H; Chamat S; Sorensen GL; Jounblat R
    Respirology; 2018 Mar; 23(3):298-305. PubMed ID: 28960651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 15q24/25 susceptibility variant for lung cancer and chronic obstructive pulmonary disease is associated with emphysema.
    Lambrechts D; Buysschaert I; Zanen P; Coolen J; Lays N; Cuppens H; Groen HJ; Dewever W; van Klaveren RJ; Verschakelen J; Wijmenga C; Postma DS; Decramer M; Janssens W
    Am J Respir Crit Care Med; 2010 Mar; 181(5):486-93. PubMed ID: 20007924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotinic acetylcholine receptor variants associated with susceptibility to chronic obstructive pulmonary disease: a meta-analysis.
    Zhang J; Summah H; Zhu YG; Qu JM
    Respir Res; 2011 Dec; 12(1):158. PubMed ID: 22176972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CHRNA3 rs1051730 and CHRNA5 rs16969968 polymorphisms are associated with heavy smoking, lung cancer, and chronic obstructive pulmonary disease in a mexican population.
    Pérez-Morales R; González-Zamora A; González-Delgado MF; Calleros Rincón EY; Olivas Calderón EH; Martínez-Ramírez OC; Rubio J
    Ann Hum Genet; 2018 Nov; 82(6):415-424. PubMed ID: 29993116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variants of pulmonary SP-D predict disease outcome of COPD in a Chinese population.
    Ou CY; Chen CZ; Hsiue TR; Lin SH; Wang JY
    Respirology; 2015 Feb; 20(2):296-303. PubMed ID: 25376584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surfactant protein D as a biomarker for chronic obstructive pulmonary disease.
    Bowler RP
    COPD; 2012 Dec; 9(6):651-3. PubMed ID: 23244171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Surfactant-Associated Protein D Gene Polymorphisms with the Risk of COPD: a Meta-Analysis.
    Liao Y; Huang C; Wang J; Fan X
    Clinics (Sao Paulo); 2019; 74():e855. PubMed ID: 31116231
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Korytina GF; Akhmadishina LZ; Viktorova EV; Kochetova OV; Viktorova TV
    Indian J Med Res; 2016 Dec; 144(6):865-876. PubMed ID: 28474623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SP-D polymorphisms and the risk of COPD.
    Shakoori TA; Sin DD; Bokhari SN; Ghafoor F; Shakoori AR
    Dis Markers; 2012; 33(2):91-100. PubMed ID: 22846212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surfactant protein D is a causal risk factor for COPD: results of Mendelian randomisation.
    Obeidat M; Li X; Burgess S; Zhou G; Fishbane N; Hansel NN; Bossé Y; Joubert P; Hao K; Nickle DC; van den Berge M; Timens W; Cho MH; Hobbs BD; de Jong K; Boezen M; Hung RJ; Rafaels N; Mathias R; Ruczinski I; Beaty TH; Barnes KC; Paré PD; Sin DD;
    Eur Respir J; 2017 Nov; 50(5):. PubMed ID: 29191953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surfactant protein D in chornic obstructive pulmonary disease (COPD).
    Moreno D; Garcia A; Lema D; De Sanctis JB
    Recent Pat Endocr Metab Immune Drug Discov; 2014 Jan; 8(1):42-7. PubMed ID: 24506680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic Variants in IL6R and ADAM19 are Associated with COPD Severity in a Mexican Mestizo Population.
    Pérez-Rubio G; Silva-Zolezzi I; Fernández-López JC; Camarena Á; Velázquez-Uncal M; Morales-Mandujano F; Hernández-Zenteno Rde J; Flores-Trujillo F; Sánchez-Romero C; Velázquez-Montero A; Espinosa de Los Monteros C; Sansores RH; Ramírez-Venegas A; Falfán-Valencia R
    COPD; 2016 Oct; 13(5):610-5. PubMed ID: 27078193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicotinic acetylcholine receptor polymorphism, smoking behavior, and tobacco-related cancer and lung and cardiovascular diseases: a cohort study.
    Kaur-Knudsen D; Bojesen SE; Tybjærg-Hansen A; Nordestgaard BG
    J Clin Oncol; 2011 Jul; 29(21):2875-82. PubMed ID: 21646606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CHRNA3 and CYP3A5*3 genotype, lung function and chronic obstructive pulmonary disease in the general population.
    Kaur-Knudsen D; Bojesen SE; Nordestgaard BG
    Pharmacogenet Genomics; 2014 Apr; 24(4):220-9. PubMed ID: 24535486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CHRNA5/CHRNA3 Locus Associates with Increased Mortality among Smokers.
    Kupiainen H; Kuokkanen M; Kontto J; Virtamo J; Salomaa V; Lindqvist A; Kilpeläinen M; Laitinen T
    COPD; 2016 Aug; 13(4):464-70. PubMed ID: 26751916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted high-throughput sequencing of candidate genes for chronic obstructive pulmonary disease.
    Matsson H; Söderhäll C; Einarsdottir E; Lamontagne M; Gudmundsson S; Backman H; Lindberg A; Rönmark E; Kere J; Sin D; Postma DS; Bossé Y; Lundbäck B; Klar J
    BMC Pulm Med; 2016 Nov; 16(1):146. PubMed ID: 27835950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of surfactant protein A, surfactant protein D, Clara cell protein 16, S100 protein, trefoil factor 3, and prostatic secretory protein 94 in idiopathic pulmonary fibrosis, sarcoidosis, and chronic pulmonary obstructive disease.
    Doubková M; Karpíšek M; Mazoch J; Skřičková J; Doubek M
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):224-234. PubMed ID: 27758987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of CHRNA5-A3 genetic Locus variants and developing drug for chronic obstructive pulmonary disease.
    Lococo F; Cesario A; Petracca-Ciavarella L; Granone P; Russo P
    Curr Med Chem; 2012; 19(34):5863-70. PubMed ID: 23061658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.